Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Comoglio

Showing results (171-180 of 228) with videos related to

Pageof 23
Sort By:
Journal of Cellular Biochemistry|January 1, 1991
Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activationL Lehtola, L Sistonen, P Koskinen, et al.
Brain Research|February 21, 1994
Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-MET) in human brain tissuesT Yamada, H Tsubouchi, Y Daikuhara, et al.
Oncogene|April 1, 1991
c-met is amplified but not mutated in a cell line with an activated met tyrosine kinaseC Ponzetto, S Giordano, F Peverali, et al.
Oncogene|November 1, 1989
Biosynthesis of the protein encoded by the c-met proto-oncogeneS Giordano, M F Di Renzo, R P Narsimhan, et al.
Biochemical and Biophysical Research Communications|May 29, 1986
PDGF-induced receptor phosphorylation and phosphoinositide hydrolysis are unaffected by protein kinase C activation in mouse Swiss 3T3 and human skin fibroblastsE Sturani, L M Vicentini, R Zippel, et al.
Cancer Research|August 2, 2001
Osteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growthE Medico, A Gentile, C Lo Celso, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Blocked and not blocked whole-ricin-antibody immunotoxins: intraperitoneal therapy of human tumour xenografted in nude miceP Brusa, F Pietribiasi, G Bussolati, et al.
The Journal of Pathology|November 1, 1996
Expression of Met protein in thyroid tumoursL P Ruco, T Ranalli, A Marzullo, et al.
Oncogene|September 28, 1999
Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonistsP Michieli, C Basilico, S Pennacchietti, et al.
Oncogene|October 1, 1992
Autophosphorylation promotes complex formation of recombinant hepatocyte growth factor receptor with cytoplasmic effectors containing SH2 domainsA Bardelli, F Maina, I Gout, et al.
Pageof 23

Showing results (171-180 of 228) with videos related to

Sort By:
Pageof 23
Journal of Cellular Biochemistry|January 1, 1991
Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activationL Lehtola, L Sistonen, P Koskinen, et al.
Brain Research|February 21, 1994
Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-MET) in human brain tissuesT Yamada, H Tsubouchi, Y Daikuhara, et al.
Oncogene|April 1, 1991
c-met is amplified but not mutated in a cell line with an activated met tyrosine kinaseC Ponzetto, S Giordano, F Peverali, et al.
Oncogene|November 1, 1989
Biosynthesis of the protein encoded by the c-met proto-oncogeneS Giordano, M F Di Renzo, R P Narsimhan, et al.
Biochemical and Biophysical Research Communications|May 29, 1986
PDGF-induced receptor phosphorylation and phosphoinositide hydrolysis are unaffected by protein kinase C activation in mouse Swiss 3T3 and human skin fibroblastsE Sturani, L M Vicentini, R Zippel, et al.
Cancer Research|August 2, 2001
Osteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growthE Medico, A Gentile, C Lo Celso, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Blocked and not blocked whole-ricin-antibody immunotoxins: intraperitoneal therapy of human tumour xenografted in nude miceP Brusa, F Pietribiasi, G Bussolati, et al.
The Journal of Pathology|November 1, 1996
Expression of Met protein in thyroid tumoursL P Ruco, T Ranalli, A Marzullo, et al.
Oncogene|September 28, 1999
Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonistsP Michieli, C Basilico, S Pennacchietti, et al.
Oncogene|October 1, 1992
Autophosphorylation promotes complex formation of recombinant hepatocyte growth factor receptor with cytoplasmic effectors containing SH2 domainsA Bardelli, F Maina, I Gout, et al.
Pageof 23